Personal CFO Solutions LLC lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 176.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,615 shares of the company’s stock after acquiring an additional 3,581 shares during the quarter. Personal CFO Solutions LLC’s holdings in Cardinal Health were worth $1,186,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Integrated Wealth Concepts LLC boosted its stake in shares of Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after buying an additional 280 shares during the period. Jones Financial Companies Lllp raised its holdings in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in Cardinal Health in the second quarter worth approximately $1,935,000. Cerity Partners LLC grew its holdings in Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after acquiring an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC grew its holdings in Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the stock. Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a report on Friday, May 1st. Morgan Stanley increased their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Evercore cut their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Wells Fargo & Company decreased their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Citigroup reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Thursday, July 2nd. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $247.80.
Cardinal Health Price Performance
NYSE CAH opened at $237.41 on Thursday. The firm’s fifty day moving average price is $211.13 and its 200 day moving average price is $212.62. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21. The company has a market capitalization of $55.60 billion, a price-to-earnings ratio of 36.30, a price-to-earnings-growth ratio of 1.18 and a beta of 0.49.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the company earned $2.35 earnings per share. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.
Cardinal Health Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is currently 31.50%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
